Back
Atara Biotherapeutics Stock Predictions
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
24
ATRA
Atara Biotherapeutics
Last Price:
$6.58
Seasonality Move:
-3.05%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Atara Biotherapeutics Stock Forecast
-
Over the next 52 weeks, Atara Biotherapeutics has on average historically fallen by 15.3% based on the past 10 years of stock performance.
-
Atara Biotherapeutics has fallen lower in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Atara Biotherapeutics Stock Undervalued?The current Atara Biotherapeutics [ATRA] share price is $6.68. The Score for ATRA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
ATRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Atara Biotherapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Atara Biotherapeutics has on average historically fallen by 15.3% based on the past 10 years of stock performance.
Atara Biotherapeutics Stock Rating
Sell
24
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics overpriced?
-
Atara Biotherapeutics has fallen lower in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Atara Biotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
atarabio.com
52-Week Data
52-Week High:
18.71
52-Week Low:
5.01
Prediction Charts
Market Cap:
39.8M
Price in USD:
6.68
Volume:
94.2K
Beta:
0.98
Technical Analysis
SMA50:
6.70
SMA100:
8.41
SMA200:
8.85
52-Wk Change:
-51.98%
Stock Predictions
-
Is Atara Biotherapeutics stock public?Yes, Atara Biotherapeutics is a publicly traded company.
-
What is the Atara Biotherapeutics stock quote today?The Atara Biotherapeutics stock price is 6.68 USD today.
-
How to buy Atara Biotherapeutics stock online?You can buy Atara Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-24 | 6.97 | 7.60 | 7.76 | 6.94 |
| Apr-25 | 7.47 | 7.32 | 7.67 | 7.10 |
| Apr-28 | 7.38 | 7.42 | 7.50 | 7.13 |
| Apr-29 | 7.40 | 7.51 | 7.60 | 7.10 |
| Apr-30 | 7.39 | 7.99 | 8.01 | 7.19 |
| May-1 | 8.01 | 7.56 | 8.03 | 7.55 |
| May-2 | 7.75 | 7.82 | 8.30 | 7.64 |
| May-5 | 7.60 | 7.25 | 7.72 | 7.25 |
| May-6 | 8.00 | 7.67 | 8.65 | 7.43 |
| May-7 | 7.60 | 7.26 | 7.64 | 7.19 |
| May-8 | 7.24 | 7.42 | 7.62 | 6.90 |
| May-9 | 7.44 | 7.27 | 7.80 | 7.27 |
| May-12 | 7.74 | 6.47 | 7.76 | 6.39 |
| May-13 | 6.50 | 6.68 | 6.94 | 6.45 |
Atara Biotherapeutics Earnings
Atara Biotherapeutics Earnings Report: Per Share Atara Biotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Atara Biotherapeutics Forecast Revenue Growth
Atara Biotherapeutics Stock Analysis: Historical quarterly revenues per share for Atara Biotherapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.57 per share, and an increase next year of $4.42 per share.
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.